These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 21440733

  • 1. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up.
    Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O.
    Transplant Proc; 2011 Mar; 43(2):458-61. PubMed ID: 21440733
    [Abstract] [Full Text] [Related]

  • 2. Obesity in renal transplantation: the role of induction therapy on long-term outcomes.
    Patel S, Pankewycz O, Kohli R, Said M, Alnimri M, Feng L, Laftavi MR.
    Transplant Proc; 2011 Mar; 43(2):469-71. PubMed ID: 21440736
    [Abstract] [Full Text] [Related]

  • 3. Prospective randomized controlled trial of rabbit antithymocyte globulin compared with IL-2 receptor antagonist induction therapy in kidney transplantation.
    Pilch NA, Taber DJ, Moussa O, Thomas B, Denmark S, Meadows HB, McGillicuddy JW, Srinivas TR, Baliga PK, Chavin KD.
    Ann Surg; 2014 May; 259(5):888-93. PubMed ID: 24513787
    [Abstract] [Full Text] [Related]

  • 4. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE, Weng RR, Piper M, Laugenou K, Ichii H, Lakey J, Malinoski D.
    Transplant Proc; 2012 Jan; 44(1):164-6. PubMed ID: 22310605
    [Abstract] [Full Text] [Related]

  • 5. Low-dose RATG with or without basiliximab in renal transplantation: a matched-cohort observational study.
    Gentile G, Somma C, Gennarini A, Mastroluca D, Rota G, Lacanna F, Locatelli B, Remuzzi G, Ruggenenti P.
    Am J Nephrol; 2015 Jan; 41(1):16-27. PubMed ID: 25612603
    [Abstract] [Full Text] [Related]

  • 6. Rabbit antithymocyte globulin versus basiliximab in renal transplantation.
    Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D, Thymoglobulin Induction Study Group.
    N Engl J Med; 2006 Nov 09; 355(19):1967-77. PubMed ID: 17093248
    [Abstract] [Full Text] [Related]

  • 7. Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection.
    Deeks ED, Keating GM.
    Drugs; 2009 Jul 30; 69(11):1483-512. PubMed ID: 19634926
    [Abstract] [Full Text] [Related]

  • 8. Long-term safety and efficacy of antithymocyte globulin induction: use of integrated national registry data to achieve ten-year follow-up of 10-10 Study participants.
    Lentine KL, Schnitzler MA, Xiao H, Brennan DC.
    Trials; 2015 Aug 19; 16():365. PubMed ID: 26285695
    [Abstract] [Full Text] [Related]

  • 9. Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.
    Flaman F, Zieroth S, Rao V, Ross H, Delgado DH.
    J Heart Lung Transplant; 2006 Nov 19; 25(11):1358-62. PubMed ID: 17097501
    [Abstract] [Full Text] [Related]

  • 10. Rabbit antithymocyte induction and dosing in deceased donor renal transplant recipients over 60 yr of age.
    Patel SJ, Knight RJ, Suki WN, Abdellatif A, Duhart BT, Krauss AG, Mannan S, Nezakatgoo N, Osama Gaber A.
    Clin Transplant; 2011 Nov 19; 25(3):E250-6. PubMed ID: 21231963
    [Abstract] [Full Text] [Related]

  • 11. Comparing Outcomes between Antibody Induction Therapies in Kidney Transplantation.
    Koyawala N, Silber JH, Rosenbaum PR, Wang W, Hill AS, Reiter JG, Niknam BA, Even-Shoshan O, Bloom RD, Sawinski D, Nazarian S, Trofe-Clark J, Lim MA, Schold JD, Reese PP.
    J Am Soc Nephrol; 2017 Jul 19; 28(7):2188-2200. PubMed ID: 28320767
    [Abstract] [Full Text] [Related]

  • 12. Basiliximab combined with low-dose rabbit anti-human thymocyte globulin: a possible further step toward effective and minimally toxic T cell-targeted therapy in kidney transplantation.
    Ruggenenti P, Codreanu I, Cravedi P, Perna A, Gotti E, Remuzzi G.
    Clin J Am Soc Nephrol; 2006 May 19; 1(3):546-54. PubMed ID: 17699258
    [Abstract] [Full Text] [Related]

  • 13. Basiliximab versus rabbit antithymocyte globulin as induction therapy for living-related renal transplantation: a single-center experience.
    Huang HF, Zhou JY, Xie WQ, Wu JY, Deng H, Chen JH.
    Int Urol Nephrol; 2016 Aug 19; 48(8):1363-1370. PubMed ID: 27170340
    [Abstract] [Full Text] [Related]

  • 14. Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.
    Thomusch O, Wiesener M, Opgenoorth M, Pascher A, Woitas RP, Witzke O, Jaenigen B, Rentsch M, Wolters H, Rath T, Cingöz T, Benck U, Banas B, Hugo C.
    Lancet; 2016 Dec 17; 388(10063):3006-3016. PubMed ID: 27871759
    [Abstract] [Full Text] [Related]

  • 15. Induction treatment with rabbit antithymocyte globulin versus basiliximab in renal transplant recipients with planned early steroid withdrawal.
    Martin ST, Roberts KL, Malek SK, Tullius SG, Vadivel N, De Serres S, Grafals M, Elsanjak A, Filkins BA, Chandraker A, Gabardi S.
    Pharmacotherapy; 2011 Jun 17; 31(6):566-73. PubMed ID: 21923440
    [Abstract] [Full Text] [Related]

  • 16. Reduced dose rabbit anti-thymocyte globulin induction for prevention of acute rejection in high-risk kidney transplant recipients.
    Klem P, Cooper JE, Weiss AS, Gralla J, Owen P, Chan L, Wiseman AC.
    Transplantation; 2009 Oct 15; 88(7):891-6. PubMed ID: 19935460
    [Abstract] [Full Text] [Related]

  • 17. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy.
    Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O.
    Transplant Proc; 2011 Mar 15; 43(2):466-8. PubMed ID: 21440735
    [Abstract] [Full Text] [Related]

  • 18. Rabbit antithymocyte globulin compared with basiliximab in kidney transplantation: a single-center study.
    Kim JM, Jang HR, Kwon CH, Huh WS, Kim GS, Kim SJ, Joh JW, Oh HY.
    Transplant Proc; 2012 Jan 15; 44(1):167-70. PubMed ID: 22310606
    [Abstract] [Full Text] [Related]

  • 19. Induction immunosuppression improves long-term graft and patient outcome in organ transplantation: an analysis of United Network for Organ Sharing registry data.
    Cai J, Terasaki PI.
    Transplantation; 2010 Dec 27; 90(12):1511-5. PubMed ID: 21057388
    [Abstract] [Full Text] [Related]

  • 20. Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial.
    Carrier M, Leblanc MH, Perrault LP, White M, Doyle D, Beaudoin D, Guertin MC.
    J Heart Lung Transplant; 2007 Mar 27; 26(3):258-63. PubMed ID: 17346628
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.